BPA for asparlas, oncaspar

Active Awarded Last action

Contract number
36E79726A0004
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 50% complete
IDV ceiling
$16,842,335.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Acquisition Center established a Blanket Purchase Agreement with Servier Pharmaceuticals LLC on October 18, 2025, against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a ceiling value of $16,842,335 and a performance period ending October 17, 2027. This BPA, which exercises option year 1 of the underlying agreement, is a single award for the supply of Asparlas and Oncaspar specialty oncology medications to support Department of Veterans Affairs healthcare services.

The BPA covers nationwide ordering to VA Veterans Integrated Service Networks across the country, with places of performance including Tennessee, California, Michigan, and Massachusetts. Orders under this vehicle are issued on a firm-fixed price basis with no set-aside designation.

Transactions

Action Obligated Date
Exercise an Option P00002 · Exercise option year 1 - BPA 36E79726A0004 $0
Supplemental Agreement for work within scope P00001 · 2026 public law pricing updates. $0
Original award $0

Quick answers

Who was awarded contract 36E79726A0004?

36E79726A0004 was awarded to Servier Pharmaceuticals LLC by National Acquisition Center (Headquarters) on October 18, 2025.

How much is contract 36E79726A0004 worth?

36E79726A0004's own ceiling is $16,842,335.

Who can order from contract 36E79726A0004?

36E79726A0004 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79726A0004 under another contract?

Yes. 36E79726A0004 is a blanket purchase agreement under 36F79720D0213, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79726A0004 competed?

The extent of competition for 36E79726A0004 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV